Boston Scientific

TheraSphere™ Y-90 Glass Microspheres: The DOSISPHERE-01 Trial

By Boston Scientific
By Boston Scientific
175 views
February 17, 2021
The DOSISPHERE-01 Trial is a level I randomized trial that showed advanced HCC patients who ...
read more ↘
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
28:04
Boston Scientific

Evolution of the HCC Treatment: Clinical and Dosimetric Recommendati…

Feat. R. Salem, E. Garin
55:42
Boston Scientific

Select Locoregional therapies as a COVID-19 Risk Mitigation treatmen…

Feat. E. Kim, R. Salem, P. Khanna, J. Gimenez
02:25
Boston Scientific

TruSelect™ Microcatheter Animation

26:23
Boston Scientific

The Changing Paradigm of Dosing and Dosimetry with Y90 Glass Microsp…

Feat. S. Young
03:37
Boston Scientific

TheraSphere™ Y-90 Glass Microspheres Animation

56:46
Boston Scientific

The Evolution of Dosimetry Using Y-90 Glass Microspheres

Feat. S. Young, R. Salem, R. Lewandowski, J. Gimenez
11:18
Boston Scientific

Dosimetry Series: Multifocal Disease

Feat. J. Gimenez
30:46
Boston Scientific

Dosimetry Series: Radiation Segmentectomy

Feat. R. Hickey
30:30
Boston Scientific

Dosimetry Series: Radiation Lobectomy

Feat. R. Lewandowski
24:55
Boston Scientific

Dosimetry Series: Introduction to Dosimetry

01:55
Boston Scientific

TheraSphere™ Y-90 Glass Microspheres: The LEGACY Study

21:02
Boston Scientific

LEGACY: A Multicenter Study Confirming TheraSphere™ as a Neoadjuvant…

Feat. V. Bishay
02:18
Boston Scientific

TheraSphere™ Y-90 Glass Microspheres: How it’s Made

32:43
Boston Scientific

Evolution of the HCC treatment: Optimized vs Standard Dosimetry

Feat. E. Garin
15:11
SIR 2023 Conference Coverage

SIR 2023: Histotripsy - Technology and Clinical Evidence

Feat. T. Ziemlewicz
24:56
Dennis Parhar

Hepatic Hilar Nerve Block for Adjunctive Analgesia during Percutaneo…

28:59
The France Foundation

Evolving Options for the Treatment of HCC With IO and Liver-Directed…

Feat. A. Smolock, B. George
10:57
UCLA Health

Y90 Radioembolization for Locally Advanced HCC

Feat. S. Padia
16:10
Malkhaz Mizandari

HCC Percutaneous Radio-Ablation Using BAT-90: Results of an Ongoing …

13:15
Penn Medicine Abramson Cancer Center

Colorectal Liver Metastases: Liver-Directed Therapies - Embolization…

Feat. M. Soulen
24:12
SIR 2022 Coverage

New and Evolving Clinical Trials: Embolotherapy

Feat. M. Soulen
33:31
Total Health

Updates in Radiation Therapy for GI Cancers

Feat. N. Sanford
22:08
Cedars Sinai

Approach to the Patient with a Liver Mass

Feat. W. Ayoub
13:45
Flavio Rocha

How to Incorporate Molecular Testing in Therapy for Localized Cholan…

21:46
Rush University Medical Center

Hepatocellular Cancer Treatments

Feat. S. Eswaran
67:23
The France Foundation

Combining Locoregional and Systemic Therapy for Challenging HCC Cases

Feat. R. Avritscher, A. O. Kaseb
11:27
Integrity Continuing Education

Hepatic Arterial Infusion for Primary Liver Cancer

Feat. K. Lafaro
26:31
Houston Methodist Hospital

Local Ablative Treatment of Small Hepatocellular Carcinoma: What Are…

Feat. L. Kulik
12:35
Integrity Continuing Education

Intermediate Stage HCC With a Hx of Cirrhosis: Case Presentation and…

Feat. M. Baretti, D. Hsieh, K. Lafaro, F. Escorcia
14:05
OncoAlert

Year in Review: Hepato-Biliary Surgical Oncology

Feat. S. Conci
23:43
Shamar Young

Dosing Radioembolization for HCC: Why Dose Calculation Is the Most I…

49:01
Masonic Cancer Center, University of Minnesota

Mechanistic Dissection and Immunotherapy of Liver Cancer

Feat. G. Feng
11:32
SIR 2024 Insights

SIR 2024 Insights: Route90 US IDE Pivotal Study Early Results in Rad…

Feat. A. Kennedy
28:20
Houston Methodist Hospital

Oncologic Liver Transplant: The New Era and Where Are We Going

Feat. A. Bandín Musa